56 related articles for article (PubMed ID: 9273011)
1. [Results and consequences of frequent quality control of quantitative clinical 1H-MR-spectroscopy].
Roser W; Steinbrich W; Radue EW
Rofo; 1997 Jun; 166(6):554-7. PubMed ID: 9273011
[TBL] [Abstract][Full Text] [Related]
2. Quantitative single-voxel spectroscopy: the reciprocity principle for receive-only head coils.
Jost G; Harting I; Heiland S
J Magn Reson Imaging; 2005 Jan; 21(1):66-71. PubMed ID: 15611950
[TBL] [Abstract][Full Text] [Related]
3. Development of a cone-shape phantom for multi-voxel MR spectroscopy.
Woo DC; Kim BS; Jung SL; Park HJ; Rhim HS; Jahng GH; Choe BY
J Neurosci Methods; 2007 May; 162(1-2):101-7. PubMed ID: 17292479
[TBL] [Abstract][Full Text] [Related]
4. [Definition criteria for a magnetic resonance quality assurance program: multicenter study].
Mascaro L; Strocchi S; Colombo P; Del Corona M; Baldassarri AM
Radiol Med; 1999 May; 97(5):389-97. PubMed ID: 10432972
[TBL] [Abstract][Full Text] [Related]
5. MRS quality assessment in a multicentre study on MRS-based classification of brain tumours.
van der Graaf M; Julià-Sapé M; Howe FA; Ziegler A; Majós C; Moreno-Torres A; Rijpkema M; Acosta D; Opstad KS; van der Meulen YM; Arús C; Heerschap A
NMR Biomed; 2008 Feb; 21(2):148-58. PubMed ID: 17458918
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative MR-Spectroscopy: implementation and quality assurance on a clinical MR-scanner].
Reinert M; Schneider P; Hofmann E; Semmler W
Z Med Phys; 2010; 20(3):176-87. PubMed ID: 20663651
[TBL] [Abstract][Full Text] [Related]
7. Calibrated magnetic resonance hydrometry: an in vitro study.
Heverhagen JT; Boehm D; Klose KJ
J Magn Reson Imaging; 2003 Apr; 17(4):472-7. PubMed ID: 12655587
[TBL] [Abstract][Full Text] [Related]
8. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
9. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
[TBL] [Abstract][Full Text] [Related]
10. Interplay between intensity standardization and inhomogeneity correction in MR image processing.
Madabhushi A; Udupa JK
IEEE Trans Med Imaging; 2005 May; 24(5):561-76. PubMed ID: 15889544
[TBL] [Abstract][Full Text] [Related]
11. Detection of hidden metabolites by localized proton magnetic resonance spectroscopy in vivo.
Weber OM; Trabesinger AH; Duc CO; Meier D; Boesiger P
Technol Health Care; 1997 Dec; 5(6):471-91. PubMed ID: 9696165
[TBL] [Abstract][Full Text] [Related]
12. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
13. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla.
Schubert F; Gallinat J; Seifert F; Rinneberg H
Neuroimage; 2004 Apr; 21(4):1762-71. PubMed ID: 15050596
[TBL] [Abstract][Full Text] [Related]
14. Spiral imaging artifact reduction: a comparison of two k-trajectory measurement methods.
Lechner SM; Sipilä PT; Wiesinger F; Kerr AB; Vogel MW
J Magn Reson Imaging; 2009 Jun; 29(6):1485-92. PubMed ID: 19472426
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance spectroscopy for measuring the biodistribution and in situ in vivo pharmacokinetics of fluorinated compounds: validation using an investigation of liver and heart disposition of tecastemizole.
Schneider E; Bolo NR; Frederick B; Wilkinson S; Hirashima F; Nassar L; Lyoo IK; Koch P; Jones S; Hwang J; Sung Y; Villafuerte RA; Maier G; Hsu R; Hashoian R; Renshaw PF
J Clin Pharm Ther; 2006 Jun; 31(3):261-73. PubMed ID: 16789992
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of GABA measurements using 2D J-resolved magnetic resonance spectroscopy.
Lymer K; Haga K; Marshall I; Sailasuta N; Wardlaw J
Magn Reson Imaging; 2007 Jun; 25(5):634-40. PubMed ID: 17540274
[TBL] [Abstract][Full Text] [Related]
17. In vivo prostate magnetic resonance imaging and magnetic resonance spectroscopy at 3 Tesla using a transceive pelvic phased array coil: preliminary results.
Kim HW; Buckley DL; Peterson DM; Duensing GR; Caserta J; Fitzsimmons J; Blackband SJ
Invest Radiol; 2003 Jul; 38(7):443-51. PubMed ID: 12821859
[TBL] [Abstract][Full Text] [Related]
18. Medical reference dosimetry using EPR measurements of alanine: development of an improved method for clinical dose levels.
Helt-Hansen J; Rosendal F; Kofoed IM; Andersen CE
Acta Oncol; 2009; 48(2):216-22. PubMed ID: 18759145
[TBL] [Abstract][Full Text] [Related]
19. A practical approach to thermography in a hyperthermia/magnetic resonance hybrid system: validation in a heterogeneous phantom.
Gellermann J; Wlodarczyk W; Ganter H; Nadobny J; Fähling H; Seebass M; Felix R; Wust P
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):267-77. PubMed ID: 15629620
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
